Ivermectin
Tocris Bioscience, part of Bio-Techne | Catalog # 1260
Positive allosteric modulator of α7 nAChRs; also positive allosteric modulator of P2X4 receptors
Discontinued Product
1260 has been discontinued.
View all Nicotinic (a7) Receptor Modulators products.
Key Product Details
Description
Positive allosteric modulator of α7 nAChRs; also positive allosteric modulator of P2X4 receptors
Product Description
Ivermectin is a positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor and the purinergic P2X4 receptor. Antihelmintic and antiviral. Also modulates glutamate- and GABA-activated chloride channels. Potentiates glycine-gated currents at low concentrations (30 nM). Inhibits replication of SARS-CoV-2 in vitro (IC50 ~ 2μM).This product is composed of both Ivermectin B1a (>90%) and Ivermectin B1b.
Product Specifications
Molecular Weight
875.10
Formula
C48H74O14 (B1a form)
Storage
Desiccate at +4°C
Purity
≥96% (HPLC)
Chemical Name
22,23-Dihydroavermectin B1
CAS Number
70288-86-7
PubChem ID
6321424
InChI Key
AZSNMRSAGSSBNP-XPNPUAGNSA-N
SMILES
O[C@H]1[C@H](C)O[C@](O[C@H]2[C@@H](O[C@](O[C@H](/C(C)=C/C[C@@]4([H])O[C@@]7(CC[C@H](C)[C@@]([H])([C@]([H])(C)C)O7)C[C@@H]6C4)[C@@H](C)/C=C/C=C3/[C@]5(O)[C@]([C@H](O)C(C)=CC5C(O6)=O)([H])OC3)([H])C[C@@H]2OC)C)([H])C[C@@H]1OC.O[C@H]8[C@H](C)O[C@](O[C@H]9[C@@H](O[C@](O[C@H](/C(C)=C/C[C@@]%11([H])O[C@@]%14(CC[C@H](C)[C@@]([H])([C@]([H])(C)CC)O%14)C[C@@H]%13C%11)[C@@H](C)/C=C/C=C%10/[C@]%12(O)[C@]([C@H](O)C(C)=CC%12C(O%13)=O)([H])OC%10)([H])C[C@@H]9OC)C)([H])C[C@@H]8OC
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 50 |
Preparing Stock Solutions
for Ivermectin
The following data is based on the product molecular weight 875.10
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 2.29 mL | 11.43 mL | 22.85 mL |
| 2.5 mM | 0.46 mL | 2.29 mL | 4.57 mL |
| 5 mM | 0.23 mL | 1.14 mL | 2.29 mL |
| 25 mM | 0.05 mL | 0.23 mL | 0.46 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Caly The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 2020 PMID: 32251768
- Shan Ivermectin, an unconventional agonist of the glycine receptor chloride channel. J.Biol.Chem. 2001 PMID: 11278873
- Khakh Allosteric control of gating and kinetics at P2X4 receptor channels. J.Neurosci. 1999 PMID: 10460235
- Krause Ivermectin: a positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor. Mol.Pharmacol. 1998 PMID: 9463487
- Adelsberger Activation of rat recombinant α1β2γ2S GABAA receptor by the insecticide iverm. Eur.J.Pharmacol. 2000 PMID: 10771281
Product Specific Notices for Ivermectin
For research use only
Loading...
Loading...
Loading...